Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 9 a 21 di 21
Titolo Data di pubblicazione Autore(i) File
Francesco Lo Coco, a distinguished hematologist and a friend 1-gen-2019 Corradini, P.; Musto, P.; Vignetti, M.
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma 1-gen-2006 Marcucci, F; Mele, A; Spada, E; Candido, A; Bianco, E; Pulsoni, A; Chionne, P; Madonna, E; Cotichini, R; Barbui, A; De Renzo, A; Dore, F; Iannitto, E; Liso, V; Martino B, ; Montanaro, M; Pagano, L; Musto, P; Rapicetta, M
Inefficacy of clarithromycin in advanced multiple myeloma: a definitive report 1-gen-2002 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; Carotenuto, M; Carella, Am
Malignant mastocytoma and angiogenesis. A tumor model to study the correlation between micro vessel density and mast cell density 1-gen-2002 G., Ranieri; R., Patruno; Passantino, Giuseppe; A., Tafaro; C., Gadaleta; Passantino, Letizia
MYC-CONTAINING DOUBLE MINUTE CHROMOSOMES IN AML: ORIGIN, STRUCTURE AND TRANSCRIPTIONAL FEATURES 1-gen-2016 L'Abbate, Alberto; Turchiano, Antonella; Tolomeo, Doron; D'Addabbo, Pietro; Lonoce, Angelo; Merla, Giuseppe; Augello, Bartolomeo; Carella, Massimo; Palumbo, Orazio; Severgnini, Marco; Cifola, Ingrid; De Bellis, Gianluca; Dolnik, Anna; van Roy, Nadine; Muhelamtter, Dominique; Haferlach, Claudia; Bullinger, Lars; Storlazzi Clelia, Tiziana.
Non treatment-related chronic myeloid leukemia as a second malignancy 1-gen-2003 Specchia, G; Buquicchio, C; Albano, F; Liso, A; Pannunzio, Alessandra; Mestice, A; Rizzi, Rita; Pastore, D; Liso, V.
Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma 1-gen-2002 Boccadoro, M; Palumbo, A; Bringhen, S; Merletti, F; Ciccone, G; Richiardi, L; Rus C, ; Bertola, A; Giaccone, L; Omedè, P; Musto, P
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi 1-gen-2014 Merli, M; Visco, C; Spina, M; Luminari, S; Ferretti, Vv; Gotti, M; Rattotti, S; Fiaccadori, V; Rusconi, C; Targhetta, C; Stelitano, C; Levis, A; Ambrosetti, A; Rossi D, ; Rigacci, L; D'Arco, Am; Musto, P; Chiappella, A; Baldini, L; Bonfichi, M; Arcaini, L
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study 1-gen-2004 Bianco, E; Marcucci, F; Mele, A; Musto, P; Cotichini, R; Sanpaolo, Mg; Iannitto, E; De Renzo, A; Martino, B; Specchia, G; Montanaro, M; Barbui, Am; Nieddu, R; Pagano, L; Rapicetta, M; Franceschi, S; Mandelli, F; Pulsoni, A
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi 1-gen-2016 Sacchi, S; Marcheselli, R; Bari, A; Buda, G; Molinari, Al; Baldini, L; Vallisa, D; Cesaretti, M; Musto, P; Ronconi, S; Specchia, G; Silvestris, F; Guardigni, L; Ferrari A, ; Chiapella, A; Carella, Am; Santoro, A; Di Raimondo, F; Marcheselli, L; Pozzi, S
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 1-gen-2008 Sacchi, S; Marcheselli, L; Bari, A; Marcheselli, R; Pozzi, S; Gobbi, Pg; Angrilli F, ; Brugiatelli, M; Musto, P; Federico, M
Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes 1-gen-2002 Musto, P; Falcone, A; Sanpaolo, G; Bisceglia, M; Matera, R; Carella, Am
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network 1-gen-2014 van de Donk, Nw; Palumbo, A; Johnsen, He; Engelhardt, M; Gay, F; Gregersen, H; Hajek, R; Kleber, M; Ludwig, H; Morgan, G; Musto, P; Plesner, T; Sezer, O; Terpos, E; Waage, A; Zweegman, S; Einsele, H; Sonneveld, P; Lokhorst, Hm
Mostrati risultati da 9 a 21 di 21
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile